Histone Deacetylation: An Important Mechanism in Inflammatory Lung Diseases

Inflammatory lung diseases are characterised by increased expression of multiple inflammatory genes that are regulated by proinflammatory transcription factors, such as NF-κ B. Gene expression is regulated by modifications such as acetylation of core histones through the concerted action of coactivators such as CBP (cAMP-response element binding protein (CREB)-binding protein) which have intrinsic histone acetyltransferase (HAT) activity and are able to recruit other HAT enzymes. Conversely gene repression is mediated via histone deacetylases (HDAC) and other corepressors. In biopsies from asthmatic subjects there is an increase in HAT activity and some reduction in HDAC activity. Both of these changes are partially reversed by corticosteroid therapy. Corticosteroids switch off inflammatory genes in asthma through a combination of a direct inhibition of HAT activity and by the recruitment of HDAC2 to the activated NF-κB-stimulated inflammatory gene complex. In chronic obstructive pulmonary disease (COPD), a corticosteroid insensitive disease, there is a reduction in HDAC activity and HDAC2 expression, which may account for the amplified inflammation and resistance to the actions of corticosteroids. The reduction in HDAC2 may be secondary to oxidative and nitrative stress as a result of cigarette smoking and severe inflammation. This may also occur to differing degrees in severe asthma, smoking asthmatic patients and cystic fibrosis. Similar mechanisms may also account for the steroid resistance seen within latent adenovirus infections. The reduction in HDAC activity induced by oxidative stress can be restored by theophylline, acting through specific kinases, which may be able to reverse steroid resistance in COPD and other inflammatory lung diseases. The modulation of HAT/HDAC activity may lead to the development of novel anti-inflammatory approaches to inflammatory lung diseases that are currently difficult to treat.

[1]  I. Adcock,et al.  Update on glucocorticoid action and resistance. , 2006, The Journal of allergy and clinical immunology.

[2]  I. Adcock,et al.  Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.

[3]  C. Monneret.  Histone deacetylase inhibitors. , 2005, European journal of medicinal chemistry.

[4]  Xiang-Jiao Yang,et al.  Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication , 2005, Molecular and Cellular Biology.

[5]  A. Chiarugi,et al.  The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension. , 2005, Trends in pharmacological sciences.

[6]  I. Rahman,et al.  Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF‐κB activation and proinflammatory cytokine release in alveolar epithelial cells , 2004 .

[7]  H. Garside,et al.  Glucocorticoid Ligands Specify Different Interactions with NF-κB by Allosteric Effects on the Glucocorticoid Receptor DNA Binding Domain* , 2004, Journal of Biological Chemistry.

[8]  I. Rahman,et al.  Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. , 2004, Biochemical pharmacology.

[9]  I. Adcock,et al.  Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages , 2004, The Journal of experimental medicine.

[10]  E. Seto,et al.  Regulation of histone deacetylase activities , 2004, Journal of cellular biochemistry.

[11]  Irfan Rahman,et al.  Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. , 2004, American journal of respiratory cell and molecular biology.

[12]  I. Adcock,et al.  Transcription factors in asthma and COPD. , 2004, IDrugs : the investigational drugs journal.

[13]  Myriam Gorospe,et al.  Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase , 2004, Science.

[14]  I. Adcock,et al.  Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. , 2004, American journal of respiratory and critical care medicine.

[15]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[16]  M. Mayo,et al.  Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase , 2004, The EMBO journal.

[17]  Steven P. Gygi,et al.  Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase , 2004, Science.

[18]  I. Adcock,et al.  Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase , 2004, The Lancet.

[19]  I. Adcock,et al.  Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. , 2004, Biochemical and biophysical research communications.

[20]  A. Papi,et al.  Oxidants and asthma , 2004, Thorax.

[21]  K. Asadullah,et al.  Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  N. Thomson,et al.  Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. , 2003, American journal of respiratory and critical care medicine.

[23]  I. Adcock,et al.  How Do Corticosteroids Work in Asthma? , 2003, Annals of Internal Medicine.

[24]  P. Montuschi,et al.  Increased exhaled 8-isoprostane in childhood asthma. , 2003, Chest.

[25]  M. Currie,et al.  A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  N. Youhnovski,et al.  Specific Nitration at Tyrosine 430 Revealed by High Resolution Mass Spectrometry as Basis for Redox Regulation of Bovine Prostacyclin Synthase* , 2003, The Journal of Biological Chemistry.

[27]  P. Barnes,et al.  Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD , 2003, Thorax.

[28]  P. Barnes.  Theophylline: new perspectives for an old drug. , 2003, American journal of respiratory and critical care medicine.

[29]  A. V. van Kuilenburg,et al.  Histone deacetylases (HDACs): characterization of the classical HDAC family. , 2003, The Biochemical journal.

[30]  I. Adcock,et al.  The effect of oxidative stress on histone acetylation and IL-8 release. , 2003, Biochemical and biophysical research communications.

[31]  M. Humbert,et al.  Difficult asthma , 2003, Allergy.

[32]  L. Klotz,et al.  Modifications of Glyceraldehyde-3-Phosphate Dehydrogenase Induced by Increasing Concentrations of Peroxynitrite: Early Recognition by 20S Proteasome , 2003, Biological chemistry.

[33]  John H. White,et al.  Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. , 2003, Molecular cell.

[34]  P. Jones,et al.  N-CoR-HDAC corepressor complexes: roles in transcriptional regulation by nuclear hormone receptors. , 2003, Current topics in microbiology and immunology.

[35]  J. Saklatvala,et al.  Dexamethasone Causes Sustained Expression of Mitogen-Activated Protein Kinase (MAPK) Phosphatase 1 and Phosphatase-Mediated Inhibition of MAPK p38 , 2002, Molecular and Cellular Biology.

[36]  W. MacNee,et al.  4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[37]  I. Adcock,et al.  Expression and activity of histone deacetylases in human asthmatic airways. , 2002, American journal of respiratory and critical care medicine.

[38]  Y. Higashimoto,et al.  Inflammatory mediator mRNA expression by adenovirus E1A-transfected bronchial epithelial cells. , 2002, American journal of respiratory and critical care medicine.

[39]  Fred Asselbergs,et al.  Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family* , 2002, The Journal of Biological Chemistry.

[40]  Christopher K. Glass,et al.  Exchange of N-CoR Corepressor and Tip60 Coactivator Complexes Links Gene Expression by NF-κB and β-Amyloid Precursor Protein , 2002, Cell.

[41]  I. Adcock,et al.  A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[42]  K. Resing,et al.  Phosphatase Inhibition Leads to Histone Deacetylases 1 and 2 Phosphorylation and Disruption of Corepressor Interactions* , 2002, The Journal of Biological Chemistry.

[43]  P. Barnes,et al.  Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[44]  W. MacNee,et al.  Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. , 2002, Molecular and cellular biochemistry.

[45]  C. Peterson.  HDAC's at work: everyone doing their part. , 2002, Molecular cell.

[46]  T. Saruta,et al.  Expression and regulation of nuclear receptor coactivators in glucocorticoid action , 2002, Molecular and Cellular Endocrinology.

[47]  S. Ghosh,et al.  The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1 , 2002 .

[48]  K. J. Macleod,et al.  Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma , 2002, Thorax.

[49]  C. Glass,et al.  Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. , 2002, Cell.

[50]  W. Elliott,et al.  Molecular mechanisms of decreased steroid responsiveness induced by latent adenoviral infection in allergic lung inflammation. , 2002, The Journal of allergy and clinical immunology.

[51]  P. Herrlich,et al.  Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor , 2001, The EMBO journal.

[52]  J. Hogg,et al.  Role of latent viral infections in chronic obstructive pulmonary disease and asthma. , 2001, American journal of respiratory and critical care medicine.

[53]  Sandy D. Westerheide,et al.  The p65 (RelA) Subunit of NF-κB Interacts with the Histone Deacetylase (HDAC) Corepressors HDAC1 and HDAC2 To Negatively Regulate Gene Expression , 2001, Molecular and Cellular Biology.

[54]  K. Flaherty,et al.  Corticosteroids in idiopathic pulmonary fibrosis , 2001, Current opinion in pulmonary medicine.

[55]  E. Olson,et al.  Identification of a Signal-Responsive Nuclear Export Sequence in Class II Histone Deacetylases , 2001, Molecular and Cellular Biology.

[56]  Eric Verdin,et al.  Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation , 2001, Science.

[57]  I. Adcock,et al.  p65-activated Histone Acetyltransferase Activity Is Repressed by Glucocorticoids , 2001, The Journal of Biological Chemistry.

[58]  J. Ashwell,et al.  Inhibition of AP-1 by the Glucocorticoid-inducible Protein GILZ* , 2001, The Journal of Biological Chemistry.

[59]  P. Paré,et al.  Amplification of inflammation in emphysema and its association with latent adenoviral infection. , 2001, American journal of respiratory and critical care medicine.

[60]  A. Wolffe,et al.  Chromatin remodeling and transcriptional activation: the cast (in order of appearance) , 2001, Oncogene.

[61]  I. Adcock,et al.  Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[62]  S. Cuzzocrea,et al.  Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. , 2001, Pharmacological reviews.

[63]  S. Schreiber,et al.  CoREST is an integral component of the CoREST- human histone deacetylase complex. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[64]  H. Magnussen,et al.  In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. , 2001, Respiratory medicine.

[65]  V. Kiermer,et al.  The emerging role of class II histone deacetylases. , 2001, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[66]  C. Allis,et al.  Histone acetyltransferases. , 2001, Annual review of biochemistry.

[67]  C. Dezateux,et al.  Inhaled corticosteroids for cystic fibrosis. , 2016, The Cochrane database of systematic reviews.

[68]  Jerry L. Workman,et al.  Sds3 (Suppressor of Defective Silencing 3) Is an Integral Component of the Yeast Sin3·Rpd3 Histone Deacetylase Complex and Is Required for Histone Deacetylase Activity* , 2000, The Journal of Biological Chemistry.

[69]  E. Olson,et al.  Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation , 2000, Nature.

[70]  K. Chung,et al.  Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice , 2000, Thorax.

[71]  I. Adcock,et al.  Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12 , 2000, Molecular and Cellular Biology.

[72]  N. Lazzeri,et al.  Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. , 2000, American journal of respiratory and critical care medicine.

[73]  P. Barnes,et al.  Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[74]  J. H. Waterborg,et al.  Steady-state Levels of Histone Acetylation in Saccharomyces cerevisiae * , 2000, The Journal of Biological Chemistry.

[75]  P. Barnes,et al.  Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis , 2000, Thorax.

[76]  I. Adcock,et al.  Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor kappaB in asthma. , 2000, American journal of respiratory and critical care medicine.

[77]  D. Shore,et al.  Sds3 (suppressor of defective silencing 3) is an integral component of the yeast Sin3[middle dot]Rpd3 histone deacetylase complex and is required for histone deacetylase activity. , 2000, The Journal of biological chemistry.

[78]  Rian,et al.  A COMPARISON OF LOW-DOSE INHALED BUDESONIDE PLUS THEOPHYLLINE AND HIGH-DOSE INHALED BUDESONIDE FOR MODERATE ASTHMA , 2000 .

[79]  W. Maziak,et al.  Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[80]  A. Bird,et al.  Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. , 1999, Genes & development.

[81]  P. Montuschi,et al.  Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. , 1999, American journal of respiratory and critical care medicine.

[82]  P. Montuschi,et al.  8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. , 1998, American journal of respiratory and critical care medicine.

[83]  W. Busse,et al.  Efficacy and safety of inhaled corticosteroids. New developments. , 1998, American journal of respiratory and critical care medicine.

[84]  R. Sakalauskas,et al.  Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. , 1997, The European respiratory journal.

[85]  P. Barnes,et al.  Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. , 1997, American journal of respiratory and critical care medicine.

[86]  M. Grunstein,et al.  HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[87]  Andrew J. Bannister,et al.  The CBP co-activator is a histone acetyltransferase , 1996, Nature.

[88]  B. Howard,et al.  The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.

[89]  D. Livingston,et al.  The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[90]  S. Schreiber,et al.  A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p , 1996, Science.

[91]  J. Šorli,et al.  Persistent adenoviral infection and chronic airway obstruction in children. , 1994, American journal of respiratory and critical care medicine.

[92]  V. Allfrey,et al.  The role of histones in the maintenance of chromatin structure. , 1965, Proceedings of the National Academy of Sciences of the United States of America.

[93]  A. Mirsky,et al.  ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS. , 1964, Proceedings of the National Academy of Sciences of the United States of America.